Calcitonin Gene-related Peptide Antagonist [EPC]

9754 reported adverse events

Drugs of this class: EPTINEZUMAB-JJMR

These side effects are most commonly reported by patients taking drugs of the Calcitonin Gene-related Peptide Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 2135
1 MIGRAINE 1565
2 HEADACHE 1024
3 THERAPEUTIC RESPONSE SHORTENED 602
4 NAUSEA 575
5 FATIGUE 526
6 THROAT IRRITATION 384
7 DRUG EFFECT LESS THAN EXPECTED 383
8 DIZZINESS 382
9 PRURITUS 343
See all common reactions for Calcitonin Gene-related Peptide Antagonist [EPC]

Drugs of the Calcitonin Gene-related Peptide Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERAPEUTIC RESPONSE DELAYED 133 0.0475
1 HEMIPLEGIC MIGRAINE 15 0.0442
2 DRUG EFFECT LESS THAN EXPECTED 383 0.0258
3 THERAPEUTIC RESPONSE SHORTENED 602 0.0181
4 MIGRAINE 1565 0.0164
5 TONGUE PRURITUS 14 0.0163
6 AURA 27 0.0145
7 INFUSION SITE RASH 19 0.0138
8 INFUSION SITE BRUISING 28 0.0130
9 INFUSION SITE DISCOMFORT 11 0.0106
See all enriched reactions for Calcitonin Gene-related Peptide Antagonist [EPC]